MoCRA Archives

Takeaways from 2024 IBA Cosmetics Convergence

LexisNexis Reed Tech was pleased to sponsor, present, and attend the recent IBA (International Beauty Association) Cosmetics Convergence Spring Symposium. In addition to having great conversations with our industry peers, we attended many educational sessions, especially those concerning the new MoCRA regulations, and are happy to share some highlights here. For more information about MoCRA requirements and deadlines, please contact [email protected]. To learn more about IBA and their upcoming events, please visit their website.

MoCRA’s Impact on Private Label Cosmetic Manufacturers: Navigating the New Era of Beauty Compliance

Life Sciences, Pharmaceutical and Cosmetics

The Modernization of Cosmetics Regulation Act (MoCRA) is here, and it’s about to shake up the industry. As the FDA gears up to implement MoCRA by July 2024, it’s time for private label manufacturers to get their ducks in a row and embrace the new era of beauty compliance.

2024 MoCRA Update: Delays, Enforcement and More

Life Sciences, Pharmaceutical and Cosmetics

As the first US cosmetic regulation in over 80 years is finally being implemented, Reed Tech is keep a close eye on all evolving mandates, requirements and deadlines to communicate all relevant information to our customers. As such, Reed Tech subject-matter experts,...

MoCRA Submission Encouraged by Dec. 29, 2023; Enforcement Delayed

Drug & Biologic Product Submissions, Pharmaceutical and Cosmetics

On November 8, 2023, the Food and Drug Administration (FDA) announced that it will be ready to accept registration and listing information for the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) by the statutory deadline of December 29, 2023 and encourages companies to meet that deadline.

FDA Releases MoCRA Draft Guidance

Drug & Biologic Product Submissions, Pharmaceutical and Cosmetics

On August 7, 2023, the Food and Drug Administration (FDA) released draft guidance providing recommendations and instructions pertaining to the collection and submission of information related to the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), specifically, to assist persons submitting cosmetic product facility registrations and product listings to FDA.

MoCRA: The Future of Cosmetic Regulations

Drug & Biologic Product Submissions, Drug Label Research, Pharmaceutical and Cosmetics

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) was signed into law on December 29, 2022. This law, which provides a major overhaul of existing cosmetic regulations, requires the Food and Drug Administration (FDA) to create Good Manufacturing Practices for all cosmetics manufacturers. The law states that these established practices must include mandatory reporting of serious adverse health events caused by cosmetic products and mandatory testing of asbestos levels. This law will also include updates to cosmetic listing requirements.

Knowledge Center

Pages for “MoCRA”

Recent Blogs

Takeaways from 2024 IBA Cosmetics Convergence

MoCRA’s Impact on Private Label Cosmetic Manufacturers: Navigating the New Era of Beauty Compliance

2024 MoCRA Update: Delays, Enforcement and More

MoCRA Submission Encouraged by Dec. 29, 2023; Enforcement Delayed

FDA Releases MoCRA Draft Guidance

MoCRA: The Future of Cosmetic Regulations

Knowledge Center

Questions?